[Clinical significance of prostate-specific antigen]. / Klinisk betydning av prostataspesifikt antigen.
Tidsskr Nor Laegeforen
; 114(2): 160-2, 1994 Jan 20.
Article
en Nor
| MEDLINE
| ID: mdl-7510073
Prostate-specific antigen has replaced acid phosphatase as a more sensitive marker of prostatic cancer. It is organ-specific but not cancer-specific. However, high serum level is more often indicative of cancer than of benign hyperplasia. The authors discuss the value of prostate-specific antigen in diagnosis and prognosis, and the indications for its use. This test should be included in the examination of men with prostatic symptoms and in men below age 70-75 with a suspicious finding in the prostate on digital rectal examination. At present, we do not recommend it for screening purposes, except in men with a family history of cancer of the prostate gland.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hiperplasia Prostática
/
Neoplasias de la Próstata
/
Antígeno Prostático Específico
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Aged
/
Humans
/
Male
Idioma:
Nor
Revista:
Tidsskr Nor Laegeforen
Año:
1994
Tipo del documento:
Article
Pais de publicación:
Noruega